| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
44,702 |
40,784 |
$4.50M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
46,830 |
40,245 |
$4.14M |
| 36415 |
Collection of venous blood by venipuncture |
42,488 |
30,706 |
$1.41M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
16,900 |
14,246 |
$1.21M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,635 |
5,131 |
$1.06M |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,952 |
6,535 |
$1.00M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,956 |
4,220 |
$980K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,587 |
4,316 |
$339K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12,462 |
9,657 |
$263K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
6,092 |
5,527 |
$251K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,202 |
1,075 |
$216K |
| G0378 |
Hospital observation service, per hour |
6,307 |
3,594 |
$135K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,203 |
7,358 |
$135K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,321 |
3,109 |
$127K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
894 |
753 |
$124K |
| 80076 |
|
20,258 |
16,999 |
$121K |
| 86900 |
|
2,808 |
2,500 |
$95K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,082 |
9,242 |
$88K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,783 |
1,505 |
$79K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,130 |
2,491 |
$72K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
37,931 |
28,682 |
$68K |
| 72131 |
|
844 |
729 |
$66K |
| 87081 |
|
6,891 |
6,525 |
$62K |
| 86850 |
|
2,424 |
2,149 |
$54K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,273 |
1,118 |
$52K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,586 |
1,531 |
$52K |
| 86901 |
|
2,696 |
2,396 |
$48K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,424 |
2,975 |
$46K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,128 |
1,006 |
$45K |
| 10060 |
|
229 |
211 |
$45K |
| 70491 |
|
134 |
128 |
$43K |
| 87430 |
|
6,482 |
6,123 |
$42K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,273 |
224 |
$41K |
| 71250 |
|
1,142 |
882 |
$41K |
| 71046 |
Radiologic examination, chest; 2 views |
5,552 |
4,770 |
$38K |
| 81003 |
|
6,487 |
5,853 |
$35K |
| 87088 |
|
6,742 |
5,903 |
$33K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,125 |
3,176 |
$30K |
| 71045 |
Radiologic examination, chest; single view |
12,401 |
10,310 |
$29K |
| 73630 |
|
1,381 |
1,269 |
$27K |
| 73610 |
|
1,159 |
1,070 |
$26K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,495 |
1,275 |
$23K |
| 73562 |
|
1,565 |
1,278 |
$23K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,168 |
4,822 |
$20K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
44,190 |
34,603 |
$20K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,149 |
2,462 |
$20K |
| 81001 |
|
12,958 |
11,087 |
$19K |
| 73130 |
|
990 |
860 |
$18K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,714 |
10,510 |
$17K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,342 |
1,247 |
$17K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,143 |
3,935 |
$17K |
| 73030 |
|
913 |
783 |
$17K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
749 |
506 |
$16K |
| 76830 |
Ultrasound, transvaginal |
1,453 |
1,390 |
$16K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,073 |
929 |
$15K |
| A9270 |
Non-covered item or service |
5,701 |
2,344 |
$15K |
| 74018 |
|
1,068 |
993 |
$14K |
| 76801 |
|
1,175 |
1,028 |
$14K |
| 87040 |
|
2,474 |
2,028 |
$13K |
| 12011 |
|
209 |
188 |
$13K |
| 82962 |
|
2,681 |
1,387 |
$13K |
| 81025 |
|
2,251 |
2,153 |
$13K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
91 |
89 |
$12K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,282 |
6,355 |
$11K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
15,968 |
10,979 |
$11K |
| 73110 |
|
521 |
452 |
$11K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
164 |
134 |
$11K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,053 |
954 |
$10K |
| 87486 |
|
1,081 |
931 |
$10K |
| 84520 |
|
4,298 |
3,745 |
$10K |
| 70486 |
|
256 |
218 |
$10K |
| 82947 |
|
4,115 |
3,438 |
$10K |
| 84132 |
|
2,780 |
2,437 |
$9K |
| 82565 |
|
4,295 |
3,739 |
$9K |
| 84295 |
|
2,772 |
2,431 |
$9K |
| 82435 |
|
2,777 |
2,438 |
$9K |
| 12001 |
|
154 |
146 |
$9K |
| 84145 |
|
2,281 |
1,884 |
$8K |
| 82374 |
|
2,741 |
2,411 |
$8K |
| 93970 |
|
589 |
493 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,372 |
923 |
$7K |
| 80051 |
|
1,518 |
1,315 |
$7K |
| 87077 |
|
2,615 |
2,236 |
$6K |
| 76775 |
|
181 |
165 |
$6K |
| 87581 |
|
702 |
635 |
$6K |
| 97161 |
|
305 |
245 |
$6K |
| 83880 |
|
2,020 |
1,656 |
$6K |
| 87428 |
|
3,073 |
2,569 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,225 |
1,823 |
$6K |
| 83735 |
|
6,663 |
5,386 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,411 |
2,037 |
$5K |
| 83605 |
|
6,419 |
5,131 |
$5K |
| 87186 |
|
2,235 |
1,922 |
$5K |
| 84484 |
|
9,611 |
7,489 |
$5K |
| 85610 |
|
7,828 |
6,415 |
$5K |
| 83690 |
|
12,382 |
10,657 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
388 |
380 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,578 |
3,140 |
$4K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
87 |
86 |
$4K |
| 93971 |
|
1,074 |
904 |
$4K |
| 85730 |
|
7,065 |
5,991 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,023 |
956 |
$3K |
| 72100 |
|
431 |
385 |
$3K |
| 73080 |
|
237 |
215 |
$3K |
| 87205 |
|
1,115 |
1,033 |
$3K |
| 87807 |
|
351 |
341 |
$3K |
| 82310 |
|
674 |
615 |
$3K |
| 85379 |
|
2,129 |
1,947 |
$3K |
| 80061 |
Lipid panel |
950 |
762 |
$3K |
| 84703 |
|
7,326 |
6,844 |
$2K |
| 85027 |
|
2,333 |
1,816 |
$2K |
| 96376 |
|
2,028 |
1,271 |
$2K |
| 97165 |
|
454 |
351 |
$2K |
| 73090 |
|
76 |
66 |
$2K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
79 |
71 |
$2K |
| 82805 |
|
365 |
291 |
$2K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
80 |
72 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,245 |
1,010 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
692 |
576 |
$2K |
| 97162 |
|
92 |
73 |
$1K |
| 93976 |
|
257 |
248 |
$1K |
| 87070 |
|
509 |
468 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,990 |
1,728 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
235 |
179 |
$1K |
| 82376 |
|
332 |
266 |
$948.24 |
| 84702 |
|
1,736 |
1,466 |
$924.75 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
326 |
318 |
$913.75 |
| 72192 |
|
13 |
12 |
$829.97 |
| 74021 |
|
63 |
59 |
$556.67 |
| 96367 |
|
65 |
54 |
$539.97 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
16 |
12 |
$529.15 |
| 87210 |
|
384 |
370 |
$509.21 |
| J1644 |
Injection, heparin sodium, per 1000 units |
21 |
14 |
$502.89 |
| 80053 |
Comprehensive metabolic panel |
1,532 |
1,275 |
$483.76 |
| 90715 |
|
129 |
110 |
$464.28 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
499 |
429 |
$380.78 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
944 |
717 |
$378.02 |
| 71101 |
|
53 |
50 |
$362.11 |
| 87046 |
|
73 |
32 |
$353.78 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
809 |
628 |
$332.54 |
| 76870 |
|
13 |
12 |
$329.95 |
| 84100 |
|
665 |
549 |
$245.67 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
145 |
111 |
$229.25 |
| 86140 |
|
1,804 |
1,577 |
$228.67 |
| 73590 |
|
177 |
160 |
$220.56 |
| J3490 |
Unclassified drugs |
517 |
427 |
$168.04 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
390 |
307 |
$134.01 |
| 87899 |
|
73 |
32 |
$125.24 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
107 |
93 |
$118.61 |
| 82150 |
|
406 |
384 |
$114.19 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
872 |
844 |
$96.24 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
57 |
51 |
$93.12 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
41 |
40 |
$85.48 |
| 82550 |
|
860 |
735 |
$59.10 |
| 82077 |
|
136 |
117 |
$58.36 |
| 83045 |
|
308 |
247 |
$27.82 |
| 86592 |
|
137 |
135 |
$22.33 |
| J7050 |
Infusion, normal saline solution, 250 cc |
145 |
113 |
$19.68 |
| 82607 |
|
127 |
101 |
$16.75 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
38 |
12 |
$8.15 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
38 |
12 |
$8.15 |
| 87045 |
|
39 |
32 |
$5.18 |
| 82040 |
|
24 |
24 |
$3.33 |
| 85384 |
|
12 |
12 |
$2.50 |
| 85652 |
|
614 |
567 |
$1.76 |
| 84075 |
|
12 |
12 |
$1.66 |
| 84450 |
|
13 |
13 |
$1.66 |
| 84460 |
|
13 |
13 |
$1.66 |
| 84155 |
|
12 |
12 |
$1.66 |
| 83615 |
|
19 |
14 |
$1.48 |
| J2704 |
Injection, propofol, 10 mg |
32 |
24 |
$0.00 |
| 86308 |
|
374 |
367 |
$0.00 |
| 87147 |
|
53 |
51 |
$0.00 |
| 73502 |
|
91 |
75 |
$0.00 |
| 82728 |
|
67 |
51 |
$0.00 |
| 73060 |
|
15 |
14 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
19 |
19 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
14 |
14 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
17 |
12 |
$0.00 |
| 80143 |
|
60 |
52 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
71 |
63 |
$0.00 |
| 80179 |
|
44 |
39 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
26 |
12 |
$0.00 |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
18 |
15 |
$0.00 |
| 94664 |
|
123 |
69 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
44 |
41 |
$0.00 |
| 84439 |
|
40 |
38 |
$0.00 |
| 92610 |
|
18 |
12 |
$0.00 |
| 82140 |
|
51 |
39 |
$0.00 |
| 84550 |
|
17 |
14 |
$0.00 |